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SCHEURINK, A. J. W., A. B. STEFFENS, H. BOURITIUS, G. 
H. DRETELER, R. BRUNTINK, R. REMIE, AND J. ZAAGSMA. 
Sympathoadrenal influence on glucose, FFA, and insulin levels 
in exercising rats. Am. J. Physiol. 256 (Regulatory Integrative 
Comp. Physiol. 25): Rl61-R168, 1989.-The effects of sympa- 
thoadrenal manipulations on the exercise-induced alterations 
in blood glucose, plasma free fatty acids (FFA), and insulin 
were investigated in intact and adrenodemedullated rats. Ex- 
ercise consisted of strenuous swimming against a countercur- 
rent for 15 min. Before, during, and after swimming, blood 
samples were taken through a permanent heart catheter. Ad- 
renodemedullation (Adm) markedly reduced the exercise-in- 
duced increase in both glucose and FFA. This effect was coun- 
teracted by intravenous infusion of epinephrine (E, 20 ng/min). 
Intravenous infusion of 50 ng E/min into Adm rats caused an 
exaggerated increase in glucose. In two additional experiments 
1) specific adrenoceptor agonists and antagonists were admin- 
istered to exercising intact and Adm rats, and 2) E or norepi- 
nephrine (NE; 20 ng/min) was infused into intact resting rats. 
The results suggest that E from the adrenal medulla directly 
affects glucose and insulin but not FFA concentrations in the 
blood. NE released from peripheral sympathetic nerve endings 
probably acts in two different ways: as neurotransmitter on 
liver and pancreas and as a hormone on adipose tissue. 
exercise; adrenal medulla, sympathetic nerve endings; adrener- 
gic agonists and antagonists 
DURING EXERCISE the sympathoadrenal system is acti- 
vated to increase the supply of glucose and free fatty 
acids (FFA) to the working muscle (4,6). Recent findings 
in our laboratory demonstrated that in rats a functional 
dissociation appears between the release of epinephrine 
(E) by the adrenal medulla and the release of norepi- 
nephrine (NE) by the peripheral nerve endings of the 
sympathetic nervous system (13). However, a complete 
dissociation does not occur in vivo, since the release of 
NE by the peripheral nerve endings is influenced by 
adrenal E via adrenergic presynaptic mechanisms (13). 
At present, data available regarding the role of the two 
branches of the sympathoadrenal system on glucose and 
FFA metabolism during exercise are conflicting. Accord- 
ing to Winder et al. (2, 3, 24), adrenal E is not essential 
for hepatic glycogenolysis. They concluded that release 
of glucose by the liver is due to the activation of hepatic 
sympathetic nerves (22, 23). In contrast, Galbo and co- 
workers (16) failed to find any effect of hepatic dener- 
vation on hepatic glucose metabolism during exercise. 
They showed in their experiments that adrenal medul- 
lary hormones enhance net glycogen breakdown in liver 
(11, 12, 16). With regard to FFA metabolism, it is gen- 
erally accepted that during exercise enhanced sympa- 
thoadrenal activity is responsible for the increase in 
lipolysis. However, almost no information is available 
with respect to the relative contribution of adrenal E 
and/or sympathetic NE in this process. The adrenal 
medulla seems to be involved, since infusion of E into 
the blood circulation resulted in enhanced plasma FFA 
levels in resting rats (19). But also NE, released after 
activation of the sympathetic nervous system, seems to 
play an important role in the release of FFA from adipose 
tissue (19, 25). However, it should be noted that white 
adipose tissue is not directly innervated by sympathetic 
nerve endings (14). 
Indirect actions of the sympathoadrenal system, for 
example on insulin release by the pancreatic P-cell, may 
also interfere with the regulation of glucose and FFA 
levels during exercise. According to Richter et al. (11, 
l2), hormones from the adrenal medulla initiate the 
reduction in plasma insulin concentrations during exer- 
cise. In addition, infusion of E into the blood circulation 
of resting rats reduced plasma insulin concentrations 
(19). On the other hand, activation of the sympathetic 
nervous system may exert a reduction in plasma insulin 
levels. It is well known that stimulation of the pancreatic 
splanchnic nerves inhibits the release of insulin from the 
P-cell of the endocrine pancreas (25). However, infusion 
of NE into the blood circulation of resting rats did not 
affect plasma insulin concentrations (19). 
In summary, during exercise catecholamines are re- 
leased from the sympathoadrenal system, and this is 
followed by an increase in glucose and FFA release. The 
aim of the present study was to distinguish the adrenal 
medullary and sympathetic influences on glucose and 
FFA metabolism during exercise. Recently we showed 
that adrenal and sympathetic nerve activity can be dis- 
sociated by means of adrenodemedullation and/or ad- 
ministration of adrenoceptor agonists and antagonists 
(13). Therefore, in the present study, exercise-induced 
alterations in blood glucose, plasma FFA, and insulin 
concentrations were measured in adrenodemedullated 
and control rats, with and without administration of 
adrenoceptor agonists and antagonists. 
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MATERIALS AND METHODS 
Animals and housing. Male Wistar rats weighing 300- 
350 g at the beginning of the experiments were used. 
They were housed individually in Plexiglas cages (25 x 
25 x 30 cm) on a 12-h light-dark cycle (0700-1900 h light 
on) at a room temperature of 20 2, 2°C. The rats had 
continuous access to food (Muracon laboratory chow) 
and water unless otherwise stated. 
Surgery. All surgery was performed under ether anes- 
thesia. All animals were provided with a silicon heart 
catheter through the right jugular vein externalized on 
the top of the skull according to the techniques described 
earlier (18). This method allows frequent repeated blood 
sampling in unanesthetized undisturbed freely moving 
rats (17,21). Whenever intravenous infusions were to be 
performed, the rats were provided with a smaller second 
silicon heart catheter implanted in the contralateral 
(left) jugular vein (19). Because of its small size, this 
second catheter did not prevent venous return from the 
head of the animals. Experiments started 1 wk after 
insertion of the heart catheter(s) when the rats were 
above preoperative weight. In certain experiments the 
rats were surgically adrenodemedullated 2 wk before the 
insertion of the heart catheter(s) to enable adrenocortical 
regeneration. During the recovery period the rats did not 
require much saline as drinking water. Adrenodemedul- 
lation was verified histologically after termination of the 
experiments. Medullary tissue was completely absent in 
the recovered rat after correct adrenodemedullation. 
Only the results of completely adrenodemedullated rats 
were presented. 
Exercise. Exercise was performed in a pool made of 
stainless steel (length, 3.00 m; width, 0.40 m; and depth, 
0.90 m) filled 70% with water of 33 t 2°C. At one end 
the pool was equipped with a starting platform (33 x 37 
cm) placed -2 cm above the water surface. This starting 
platform could be lowered into the water down to the 
bottom of the swimming pool. A water pump (Loewe, 
Silenta) provided a marked countercurrent (0.22 m/s) 
that forced the animal to swim continuously. At the end 
of the exercise period, a removable resting platform (20 
x 37 cm) was offered to the swimming rat at the upstream 
side of the swimming pool. The rats readily learned to 
climb on this lighted and warmed platform within 2 min 
after it was presented. The rats were accustomed to the 
experimental exercise conditions six to seven times be- 
fore the onset of the actual experiments to eliminate 
emotional stress of novelty. 
Blood-sampling procedure. Forty minutes before the 
start of an experiment, the animals were connected with 
a polyethylene blood-sampling tube (0.4 m length; 1.45 
mm OD, and 0.75 mm ID) through which blood was 
sampled as described earlier (17). Blood samples of 0.35 
ml were withdrawn for determination of blood glucose, 
plasma FFA, and insulin concentrations. After each 
blood sample, a transfusion of 0.35 ml of titrated donor 
blood was given to avoid diminution of the blood volume 
with related changes in hemodynamics. Donor blood was 
obtained from unstressed rats with permanent heart 
catheters. Between the withdrawal of blood samples, the 
tip of the heart catheter was filled with 6% citrate 
solution as an anticoagulant. Citrate was used to avoid 
activation of endothelial lipase. 
Experimental procedure. All experiments were per- 
formed in the light period between 1000 and 1300 h. On 
the experimental day, food was removed 1.5 h before the 
onset of the experiment. To measure basal levels of the 
blood components, two blood samples in a lo-min inter- 
val (at t = -11 and -1 min) were taken in the home cage 
of the undisturbed rat. Subsequently, the rat was placed 
for 20 min on the starting platform of the swimming 
pool. Blood samples were taken at t = 1.5, 10, and 20 
min after the transfer from home cage to starting plat- 
form. Immediately after the t = 20-min blood sample, 
the starting platform was slowly lowered to the bottom 
of the swimming pool. This lasted for -5 min, and after 
-2 min, one blood sample was taken. The moment the 
rat started to swim was defined as t = 0 min. Then the 
animal had to swim vigorously against the countercur- 
rent for 15 min. Blood samples were taken at t = 1, 5, 
10, and 15 min. At the end of the exercise period, the 
resting platform was lowered. Postexercise blood samples 
were taken at t = 19, 24, 29, and 39 min. 
Administration of pharmacological compounds. In ex- 
periment III, adrenoceptor agonists and antagonists were 
intravenously administered before and during exercise. 
Administration of the adrenoceptor agonists E and fen- 
oterol was performed by infusion of the drug through the 
small second heart catheter. The infusion was started 
immediately after the last blood sample on the starting 
platform (t = 20 min), and the infusion was continued 
for 20 min, i.e., during the lowering of the starting 
platform and the exercise period. E infusion rates were 
20 and 50 ng in 0.1 ml saline/min. Ascorbic acid (0.1%) 
was added to prevent oxidation of E. The ,&-selective 
adrenoceptor agonist fenoterol (Boehringer-Ingelheim) 
was infused at a rate of 7 pg in 0.1 ml saline/min. The 
adrenoceptor antagonists ICI 118551 (&selective, ICI 
Pharma) and yohimbine &-selective, Sigma) were given 
in a single dose (0.1 and 0.13 mg/rat, respectively) before 
exercise. They were dissolved in 0.1 ml saline and in- 
jected intravenously together with the donor blood after 
the blood sample at t = 10 min on the starting platform. 
Chemical determinations. Blood samples were imme- 
diately transferred to chilled (OOC) centrifuge tubes con- 
taining 0.01% EDTA and 10 ~1 heparin solution (500 U/ 
ml) as an anticoagulant. Blood glucose was measured by 
the ferricyanide method of Hoffman (Technicon 
AutoAnalyzer TM II) with 0.05 ml blood taken from the 
0.35-ml sample. The remaining 0.3 ml blood was centri- 
fuged for 15 min at 5,000 rpm at 4°C. A part of the 
supernatant (100 ~1) was used for the FFA assay, and 
100 ~1 plasma were stored at -30°C for the insulin assay. 
Plasma FFA were determined in 100 ~1 of supernatant 
according to the method of Antonis (1) by adapting it 
for a small volume. The plasma was immediately ex- 
tracted, and the evaporated extracts were stored at 
-30°C until determination. Rat-specific plasma immu- 
noreactive insulin was determined by means of a radio- 
immunoassay kit (NOVO, Denmark). Guinea pig serum 
M8309 served as antiserum. Duplicate assays were per- 
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insulin was separated by means of a polyethylene glycol 
solution (23.75% wt/wt) as suggested by Henquin et al. 
(8) 
Statistics. Data are expressed as average change t SE 
from the basal value at t = -1 min in the home cage. 
Wilcoxon matched-pairs signed-rank test was used when 
the levels of the blood components at a certain time 
during the experiment were compared with the basal 
value in the home cage. Analysis of variance and Mann- 
Whitney U test were applied to determine for each 
sample point the significant differences between a defin- 
itive experiment and the control experiment. The crite- 
rion of significance was set at P C 0.05. 
EXPERIMENTSANDRESULTS 
Experiment I. Control experiment. The aim of the 
control experiment was to study the effect of exercise on 
blood glucose, plasma FFA, and insulin concentrations 
under the given experimental conditions. Twelve rats, 
well accustomed to the whole experimental procedure, 
participated in this study. The results are presented in 
Table 1 and Fig. 1. Table 1 shows the absolute basal 
levels at t = -1 min, in the home cage, of blood glucose, 
plasma FFA, and insulin in all experiments, and Fig. 1 
presents the changes toward basal values in blood glu- 
cose, plasma FFA, and insulin in the control experiment. 
Ten minutes after transfer of the rat to the starting 
platform, blood glucose concentrations were significantly 
augmented above basal levels. A further increase in blood 
glucose occurred after 15 min of exercise. Blood glucose 
levels were maximal at t = 19 and 24 min; thereafter a 
rapid decrease occurred. Plasma FFA levels increased 
during exercise with maximal levels in the first two blood 
samples after swimming. The increase in plasma FFA 
above basal levels was significant at the time points t = 
10, 15, 19, 24, 29, and 39 min during and after exercise. 
Plasma insulin concentrations were slightly but not sig- 
nificantly reduced in the period on the starting platform. 
During exercise a further significant decline in insulin 
levels occurred. After exercise, plasma insulin returned 
TABLE 1. Basal values of plasma FFA, blood glucose, 
and plasma insulin 
n 
Plasma FFA, Blood Glucose, Plasma Insulin, 
peq/ml w/d dJ/ml 
Control (expt I) 12 0.12kO.016 
Adm (expi II) 9 0.13t0.028 
ICI 118551 (expt 9 0.17kO.032 
IIIa) 
Adm + fenoterol 4 0.13kO.020 
(expt IIIb) 
Adm + 20E ng E 6 0.14kO.023 
(expt IIIc) 
Adm+50EngE 5 0.15kO.032 
(expt IIId) 
Adm + yohimbine + 4 0.10t0.019 
fenoterol (expt 
IIIe) 
E infusion (expt IVa) 7 0.16kO.027 




















Values are means t SE; n, no. of rats. FFA, free fatty acids; Adm, 
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FIG. 1. Plasma free fatty acids (FFA), blood glucose (glut), and 
plasma insulin (ins) concentrations before, during, and after exercise 
(M). Data for FFA, glucose, and insulin are expressed as average 
changes t SE from basal values. (Basal value was measured at t = -1 
min in home cage, immediately before rat was transferred to starting 
platform in swimming pool.) Swimming period is indicated by dotted 
area. 
to basal levels with a slight decline in the last samples 
at t = 29 and 39 min. Plasma insulin levels were signifi- 
cantly changed from basal levels at t = 5, 10, 15, and 39 
min during and after exercise. 
Experiment II. Adrenodemedullation. Nine bilaterally 
adrenodemedullated (Adm) rats were submitted to exer- 
cise to investigate the role of the adrenal medulla on 
blood glucose, plasma FFA, and insulin concentrations 
during exercise. The results are presented in Table 1 and 
Fig. 2. Basal levels of plasma insulin in Adm rats were 
significantly lower than the control values in intact rats. 
The exercise-induced increase in blood glucose and FFA 
was reduced in Adm rats (significant at t = 1, 5, 10, 15, 
19,24, and 29 min for glucose and t = 19,24, and 29 min 
for FFA). The alternations in plasma insulin concentra- 
tions during exercise in Adm rats were not different from 
those in the control experiments. During recovery on the 
resting platform, a significant reduction in plasma insu- 
lin concentrations in Adm rats in comparison with the 
control values occurred at t = 24 and 29 min postexercise. 
Experiment III. Presynaptic regulatory mechanisms. 
Pharmacological modulations of the presynaptic regula- 
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FIG. 2. Effect of adrenodemedullation on plasma free fatty acids 
(FFA), blood glucose (glut), and plasma insulin (ins) concentrations 
before, during, and after exercise (M). Control experiment with 
intact rats is depicted (0-- -0). Data are expressed as average changes 
t SE from basal value. Swimming period is indicated by dotted area. 
catecholamine levels in exercising intact and Adm rats 
(13). The effect of these pharmacological interventions 
on blood glucose, plasma FFA, and insulin were investi- 
gated in this composed experiment. 
In Experiment 11&.z, the &-selective adrenoceptor an- 
tagonist ICI 118551 was administered intravenously into 
six intact rats to suppress NE release from the peripheral 
nerve endings of the sympathetic nervous system (13). 
The effects on blood glucose, plasma FFA, and insulin 
are presented in Table 1 and Fig. 3A. The injection of 
the ,&-antagonist reduced blood glucose for the rest of 
the experiment in comparison with the control experi- 
ment (significant at all sample times except for t = 39 
min). Plasma FFA levels were slightly reduced during 
exercise (significant during lowering of the starting plat- 
form), and plasma insulin concentrations were not sig- 
nificantly changed in comparison with the control exper- 
iment. In experiment Mb, the ,&selective adrenoceptor 
agonist fenoterol was infused intravenously during ex- 
ercise into five Adm rats. This led to high plasma NE 
concentrations (13). The results are presented in Table 
1 and Fig. 3B. Blood glucose, plasma FFA, and insulin 
were increased in comparison with Adm rats (significant 
at t = 5. 10, 15, 19, 24. 29, and 39 min for glucose, at t = 
.16, 
.08, 
I  ,  I  ,  I  ,  ,  ,  1 
0 0 15 min 0 0 15 min 
FIG. 3. A: effect of intravenous administration of ,&-selective adre- 
noceptor antagonist ICI 118551 on plasma free fatty acids (FFA), blood 
glucose (glut), and plasma insulin (ins) concentrations in exercising 
adrenodemedullated (Adm) rats (M). Control experiments with 
intact (- - -) and Adm (- ) rats are depicted. Data are expressed as 
average changes ~fr SE from basal values. Swimming period is indicated 
by dotted area. Time point of injection is indicated by an arrow. B: 
effect of an intravenous infusion of the &selective adrenoceptor ago- 
nist fenoterol on plasma FFA, blood glucose, and plasma insulin con- 
centrations in exercising Adm rats (u). Control experiments with 
intact and Adm rats are depicted (- - - and -), respectively. Period 
in which infusion was given is indicated by a horizontal line at bottom 
of each graph. Data are expressed as in A. See facing page for C-E. 
.16 
.08 
1, 5, and 10 min for FFA, and at all time points during 
and after infusion for insulin). 
In experiment MC, a physiological dose (20 ng/min) of 
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rats to restore the normal NE and probably also E experiment were not different from Adm and/or normal 
pattern (13). Blood glucose, plasma FFA, and insulin values. Experiment IIIe consisted of a single intravenous 
alterations are presented in Table 1 and Fig. 3C. Blood injection of the az-selective adrenoceptor antagonist yo- 
glucose and plasma FFA were significantly enhanced himbine at t = 10 min on the starting platform combined 
above Adm levels at t = 1, 5, 10, 15, 19, 29, and 39 min with an intravenous infusion of the &-selective adreno- 
for glucose and at t = 19 and 24 min for FFA. Blood ceptor agonist fenoterol during exercise in four Adm rats. 
glucose and plasma FFA levels showed a remarkable This leads to extremely high plasma NE concentrations 
similarity with the values in normal exercising rats in (13). The results are presented in Table 1 and Fig. 3E. 
the control experiment. Plasma insulin levels were not Injection of the az-adrenoceptor blocker caused an in- 
changed during infusion in comparison with Adm or crease in plasma insulin concentration and a decline in 
normal exercising rats. Infusion of a high dose (50 ng/ blood glucose. Plasma FFA seemed not affected by cy2- 
min) of E into five Adm rats (expt IIId, results in Table blockade. An increase in blood glucose levels occurred 
1 and Fig. 30) caused a steep increase in blood glucose. during infusion of the ,&-antagonist fenoterol and exer- 
Blood glucose levels were significantly increased above cise. The increase in insulin was enhanced by infusion 
Adm values at t = 5 until 29 min and above control of fenoterol during exercise. Plasma levels of insulin after 
values at t = 10 until 29 min. Plasma FFA levels did not combined an-blockade and ,&-stimulation were higher 
differ from Adm values. Plasma insulin levels in this than when only fenoterol was infused without injection 
’ 0 15 mm 
FIG. 3 continued. C.- effect of an in- 
travenous infusion of 20 ng epinephrine 
(E)/min on plasma FFA, blood glucose, 
and plasma insulin concentrations in ex- 
ercising Adm rats (M). Control ex- 
periments with intact (- - - -) and Adm 
( -) rats are depicted. Data are ex- 
pressed as in B. D: effect of an intrave- 
nous infusion of 50 ng E/min on plasma 
FFA, blood glucose, and plasma insulin 
concentrations in exercising Adm rats 
(M). Control experiments with intact 
( - - - -) and Adm (-) rats are de- 
picted. Data are expressed as in B. E: 
effect of intravenous injection of the 
crz-selective adrenoceptor antagonist yo- 
himbine in combination with an intra- 
venous infusion of the &-selective adre- 
noceptor agonist fenoterol on plasma 
FFA, blood glucose, and plasma insulin 
concentrations in exercising Adm rats 
(w). Control experiments with intact 
( - - - -) and Adm (-) rats are de- 
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of yohimbine. Plasma FFA were increased during feno- 
terol infusion in this combined experiment. Plasma con- 
centrations were significantly changed in comparison 
with Adm values at t = 20, during lowering, 5, 10, 15, 19, 
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FFA, and t = 1, 5, 10, 15, 19, 24, 29, and 39 min for 
insulin. 
Experiment IV. Intravenous infusion of E and NE. To 
investigate the hormonal effects of E and NE on blood 
glucose, plasma FFA, and insulin concentrations, either 
E (20 ng in 0.1 ml saline/min) or NE (20 ng in 0.1 ml 
saline/min) was infused for 15 min into the blood circu- 
lation of seven resting rats. The infusion was adminis- 
tered through the small heart catheter between t = 0 and 
15 min, and blood samples were withdrawn at t = -11, 
-1, 1, 5, 10, 15, 17, 22, 27, and 37 min for determination 
of blood glucose, plasma FFA, and insulin. The results 
are presented in Table 1 and Fig. 4, A and B. Infusion of 
20 ng E into the blood circulation caused a significant 
increase in blood glucose within 10 min after start of the 
infusion. Plasma insulin levels were reduced during E 
infusion and increased immediately after termination of 
the infusion. Plasma FFA levels were not changed during 
infusion of E but a reduction in plasma FFA concentra- 
tions occurred after termination of the infusion. The 
changes in blood glucose, plasma FFA, and insulin were 
significant at t = 10, 15, 17, 22, 27 min, t = 27 min, and 
t = 1 min, respectively. Infusion of 20 ng NE/min had 
only an effect on plasma FFA concentrations. Plasma 
FFA levels were significantly increased at t = 22 min. 
DISCUSSION 
Blood glucose and plasma FFA concentrations in- 
creased during exercise in control rats, suggesting that 
the production and release of glucose and FFA highly 
exceeded the expenditure of these energy substrates. 
Plasma insulin levels declined, probably due to a dimin- 
ished release of insulin by the pancreatic ,&cell (6). These 
changes in glucose, FFA, and insulin concentrations G 
the result of an activation of the sympathoadrenal system 
during exercise, as reflected by increased concentrations 
of E and NE in the blood circulation (4, 6, 13). Accord- 
ingly, blood glucose and plasma FFA concentrations are 
affected by alterations in sympathoadrenal activity. Re- 
cently (13) we showed that Adm caused a 60% reduction 
in the exercise-induced increase in plasma NE concen- 
trations. Plasma E was not detectable in Adm rats. In 
the present study, Adm led to a marked reduction in the 
exercise-induced increase in both blood glucose and 
plasma FFA concentrations. The reduced catecholamine 
levels in the Adm rats had only a minor effect on plasma 
insulin alterations during exercise. This seemingly sug- 
gests that the markedly reduced increase in sympathetic 
activity as indicated by low plasma NE levels in Adm 
rats is still sufficient to inhibit insulin release during 
exercise. However, it should be noted that different blood 
glucose levels in Adm and control rats may interfere with 
FIG. 4. A: effect of an intravenous infusion of 20 ng epinephrine 
(E)/min (u) on plasma free fatty acids (FFA), blood glucose (glut), 
and plasma insulin (ins) concentrations in nonexercising rats. Data are 
expressed as average changes k SE from basal values at t = -1 min 
before start of infusion. Period in which infusion was given is indicated 
by a horizontal line at bottom of each graph. B: effect of an intravenous 
infusion of 20 ng NE/min (u) on plasma FFA, blood glucose, and 
plasma insulin concentrations in nonexerciseing rats. Data are ex- 
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the regulation of insulin release by the sympathoadrenal 
system. 
Infusion of 20 ng E/min into Adm rats completely 
restored the normal increase in plasma NE levels during 
exercise (13). In the present study the infusion of 20 ng 
E/min into Adm rats also restored blood glucose and 
plasma FFA patterns toward control values (see Fig. 3C). 
Infusion of a high dose of E (50 ng/min) into exercising 
Adm rats caused an exaggerated increase in blood glucose 
compared with control animals and Adm rats infused 
with 20 ng E/min (see Fig. 30). Plasma FFA concentra- 
tions were lower than control values after infusion of 50 
ng E/min and did not differ from those of exercising 
Adm rats. These results suggest a relation between 
plasma E and blood glucose concentrations. In a previous 
study with nonexercising rats (19), however, we showed 
that intravenous infusion of 50 ng E/min increased 
plasma FFA concentrations besides an increase in blood 
glucose and a decrease in plasma insulin. This seems in 
contrast to the results of the present study. It might be 
that the increase in plasma FFA after infusion of 50 ng 
E in the nonexercising animals may be due to a change 
in the rate of reesterification of FFA. Because insulin is 
required for this process, reduced plasma insulin concen- 
trations during 50-ng E infusion in the previous study 
may have led to reduced reesterification and then to an 
increase in plasma FFA concentrations. In the present 
study a near-physiological dose of 20 ng E/min was 
infused into nonexercising rats. This still resulted in an 
increase in blood glucose and a reduction in plasma 
insulin during infusion (see Fig. 4A). Plasma FFA con- 
centrations were not affected. Accordingly, E in a phys- 
iological range does not directly influence lipolysis. After 
termination of the E infusion plasma insulin concentra- 
tions were increased, and blood glucose returned to prein- 
fusion levels. The facilitated entry of glucose into adi- 
pocytes, affected by insulin, probably caused an increase 
in the reesterification of FFA, resulting in a decline in 
plasma FFA concentrations immediately after termina- 
tion of the infusion. 
In conclusion, the results of the present study with 
exercising and nonexercising rats suggest that E, origi- 
nating from the adrenal medulla (13), directly affects 
blood glucose and plasma insulin concentrations. The 
effects of E on plasma FFA concentrations seems sec- 
ondary to the alterations in blood glucose and in partic- 
ular plasma insulin concentrations. 
Circulating NE appeared to act exactly in the opposite 
way. In exercising Adm rats, infusion of 20 ng E restored 
both plasma NE (13) as well as plasma FFA concentra- 
tions toward control values (see Fig. 3C). After infusion 
of the high dose of 50 ng E in exercising Adm rats, both 
plasma NE (13) and FFA levels were relatively reduced 
(see Fig. 30). In nonexercising rats, infusion of 20 ng 
NE/min increased plasma FFA concentrations (see Fig. 
4B). Blood glucose and plasma insulin concentrations 
were not influenced by NE infusion. The same results 
were also obtained with a higher dose (50 ng/min) of NE 
in a previous study (19). These findings suggest a relation 
between plasma NE and plasma FFA concentrations. 
However, it has to be borne in mind that the present 
results regarding NE are only appropriate for a hormonal 
function of sympathetic NE. We recently proposed that 
all NE in plasma originates from the peripheral nerve 
endings of the sympathetic nervous system (13). After 
sympathetic activation only a small part of the released 
neurotransmitter NE leaks to the blood circulation. Ac- 
cordingly, intravenous infusion of 20 ng NE/min into 
the general blood circulation seems to be insufficient to 
mimic local sympathetic activity in peripheral organs 
such as liver or endocrine pancreas. This implies that 
the increase in plasma FFA concentrations during intra- 
venous infusion of 20 ng NE/min may be considered as 
a hormonal effect of NE on adipose tissue. This hormonal 
effect of NE on FFA release seems very functional, since I 
white adipose tissue is not directly innervated by the 
sympathetic nervous system (14). 
Infusion of the &selective adrenoceptor agonist fen- 
oterol in exercising Adm rats immediately enhanced 
blood glucose, plasma FFA, and plasma insulin concen- 
trations (see Fig. 3B). The effects on blood glucose and 
plasma insulin were seemingly caused by a direct stim- 
ulation of Pa-adrenoceptors on liver, muscle, and pan- 
creatic P-cells (9, 11, 12, 25). The decrease in blood 
glucose and plasma insulin concentrations after admin- 
istration of the ,&-selective adrenoceptor antagonist ICI 
118551 to intact exercising rats in the present study may 
indicate the involvement of ,&-adrenoceptors in the reg- 
ulation of blood glucose and plasma insulin concentra- 
tions. However, it has to be remarked that according to 
literature, catecholaminergic activation of hepatic gly- 
cogenolysis is mediated by a-adrenoceptors rather than 
by ,&adrenoceptors in adult male rats (5, 20). Alterna- 
tively, the increase of blood glucose might be explained 
by increased muscle glycogenolysis resulting in decreased 
‘uptake of glucose from the blood. Injection of the CY~- 
adrenoceptor antagonist yohimbine reduced blood glu- 
cose (see Fig. 3E), suggesting that also az-adrenoceptors 
are involved in the regulation of blood glucose levels. 
These cr2-adrenoceptors are located in liver where they 
stimulate glycogenolysis (5, 22). Because the present 
study was performed in Adm rats, the decline in blood 
glucose after an-blockade suggests that sympathetic NE 
may have activated the an-adrenoceptors in liver. This is 
in accordance with findings of Shimazu (14) and Yama- 
guchi (26). The results of the experiments in which CX~- 
and Pa-selective adrenoceptor agonists and antagonists 
were administered have to be interpreted cautiously be- 
cause of abnormal blood glucose, plasma FFA, and in- 
sulin profiles leading to deviating interactions in glyco- 
genolysis, glycogenesis, lipolysis, and lipogenesis. In ad- 
dition, interference with intermediary metabolism, e.g., 
lactate and glycerol production and changed hormone 
release, e.g., adrenocorticotropic hormone may have oc- 
curred. For example, plasma FFA concentrations in- 
creased during fenoterol infusion, which then should be 
due to a direct action of fenoterol on ,&-adrenoceptors in 
adipose tissue. However, according to literature (10, 15), 
lipolysis is preferentially mediated via a ,&adrenoceptor 
mechanism. An alternative explanation might be that 
infusion of fenoterol in exercising Adm rats immediately 
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presynaptic &adrenoceptors on the sympathetic nerve 
endings (13). Then the high NE levels might have in- 
creased lipolysis by ,&-adrenoceptor stimulation. Further 
11 
’ 
studies have to be performed to unravel the specific CY- 
and ,&adrenergic effects on blood glucose, plasma FFA, 
and insulin and in addition on metabolism. 12. 
In summary, the results of the present study suggest 
that E from the adrenal medulla directly affects glucose 
and insulin concentrations in the blood. E probably has 13. 
no direct effect on FFA release. NE released by the 
peripheral nerve endings of the sympathetic nervous 
system acts in two different ways: a neurotransmitter 14. 
function on liver and pancreas P-cell and a hormone 
function on FFA release on adipose tissue. 
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